GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CuraScientific Corp (OTCPK:CSTF) » Definitions » Gross Margin %

CuraScientific (CuraScientific) Gross Margin % : 47.83% (As of Sep. 2023)


View and export this data going back to . Start your Free Trial

What is CuraScientific Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. CuraScientific's Gross Profit for the three months ended in Sep. 2023 was $0.11 Mil. CuraScientific's Revenue for the three months ended in Sep. 2023 was $0.23 Mil. Therefore, CuraScientific's Gross Margin % for the quarter that ended in Sep. 2023 was 47.83%.


The historical rank and industry rank for CuraScientific's Gross Margin % or its related term are showing as below:

CSTF' s Gross Margin % Range Over the Past 10 Years
Min: 49.48   Med: 64.71   Max: 70
Current: 49.48


During the past 3 years, the highest Gross Margin % of CuraScientific was 70.00%. The lowest was 49.48%. And the median was 64.71%.

CSTF's Gross Margin % is ranked better than
55.76% of 990 companies
in the Drug Manufacturers industry
Industry Median: 46.5 vs CSTF: 49.48

CuraScientific had a gross margin of 47.83% for the quarter that ended in Sep. 2023 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for CuraScientific was 0.00% per year.


CuraScientific Gross Margin % Historical Data

The historical data trend for CuraScientific's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CuraScientific Gross Margin % Chart

CuraScientific Annual Data
Trend Dec20 Dec21 Dec22
Gross Margin %
70.00 63.95 64.71

CuraScientific Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 50.34 47.83

Competitive Comparison of CuraScientific's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, CuraScientific's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CuraScientific's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CuraScientific's Gross Margin % distribution charts can be found below:

* The bar in red indicates where CuraScientific's Gross Margin % falls into.



CuraScientific Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

CuraScientific's Gross Margin for the fiscal year that ended in Dec. 2022 is calculated as

Gross Margin % (A: Dec. 2022 )=Gross Profit (A: Dec. 2022 ) / Revenue (A: Dec. 2022 )
=0 / 0.034
=(Revenue - Cost of Goods Sold) / Revenue
=(0.034 - 0.012) / 0.034
=64.71 %

CuraScientific's Gross Margin for the quarter that ended in Sep. 2023 is calculated as


Gross Margin % (Q: Sep. 2023 )=Gross Profit (Q: Sep. 2023 ) / Revenue (Q: Sep. 2023 )
=0.1 / 0.23
=(Revenue - Cost of Goods Sold) / Revenue
=(0.23 - 0.12) / 0.23
=47.83 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


CuraScientific  (OTCPK:CSTF) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

CuraScientific had a gross margin of 47.83% for the quarter that ended in Sep. 2023 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


CuraScientific Gross Margin % Related Terms

Thank you for viewing the detailed overview of CuraScientific's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


CuraScientific (CuraScientific) Business Description

Traded in Other Exchanges
N/A
Address
51544 Cesar Chavez Street, Suite No. 1J, Coachella, CA, USA, 92236
CuraScientific Corp manufactures commercial chemicals with a variety of commercial sterilization applications for agriculture, warehousing, hospitality, and medical facilities. The company's product, DiOx+, is a disinfectant sterilizer that kills harmful pathogens without exposing people or the environment to dangerous toxins.
Executives
Paul Quentin Goyette director 2205 LOCH WAY, EL DORADO HILLS CA 95762
William Joseph Reed director, officer: Chief Executive Officer 333 N UNIVERSITY AVE., #33, REDLANDS CA 92374
Johann Loewen director C/O METHES ENERGIES INTERNATIONAL LTD, 3651 LINDELL ROAD, SUITE D-272, LAS VEGAS NV 89103
Edouard Maurice Beaudette director 13480 N BLOOMFIELD ROAD, NEVADA CITY CA 95959
Justin Michael Gonzalez director, officer: Chief Executive Officer 15723 LAKE VERA PURDON RD., NEVADA CITY CA 95959
Eric Jason Watson director, officer: Chief Operating Officer 19553 BOWERS DRIVE, TOPANGA CA 90290

CuraScientific (CuraScientific) Headlines

From GuruFocus

Introducing Leaf of Faith

By Marketwired Marketwired 03-26-2019